NHS Bath and North East Somerset, Swindon and Wiltshire CCG Royal United Hospitals Bath NHS Foundation Trust Great Western Hospitals NHS Foundation Trust Salisbury NHS Foundation Trust
Oral solutionSF 10mg in 5ml prohibitively expensive (Aug 19)
Notes:
Loprazolam & temazepam both have short duration of action and have no active metabolites.
Temazepam is a Schedule 3 controlled drug; a maximum of 30 days supply for all controlled drugs is the good practice advice from the Department of Health. Ref: Safer Management of Controlled Drugs, May 2007
15.01.04.01
Benzodiazepines
15.01.04.02
Non-opioid analgesics
Ketorolac (injection)
Formulary
30mg in 1ml amp
Licensed for use in short-term management of moderate to severe post operative pain only.
Contains a small amount of ethanol per dose (100mg)
See palliative care section Chapter 21
15.01.04.03
Opioid analgesics
Alfentanil (injection)
Formulary
1mg in 2ml amp
5mg in 10ml amp
5mg in 1ml amp intensive care injection
Note - also included as an AMBER TLS drug in SWINDON ONLY for use in palliative care. See here
Fentanyl (Injection)
Formulary
100 micrograms in 2ml amp
500 micrograms in 10ml amp
Remifentanil (injection)
Formulary
1mg vial
2mg vial
5mg vial
15.01.04.04
Other drugs for sedation
Dexmedetomidine (IV)
Formulary
GWH ICU/theatres only
100 micrograms/ml concentrate for solution for infusion, various ampoule sizes
....
Non Formulary Items
Parecoxib
(Dynastat®)
Non Formulary
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
High Cost Drug Approval System
Traffic Light Status Information
Status
Description
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.
Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.
Suitable for patient to be directed to buy themselves
Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.
(In use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.
Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.
